Stocklytics Platform
Asset logo for symbol MET
MetLife
MET68
$83.92arrow_drop_up0.37%$0.31
S&P500
Asset logo for symbol MET
MET68

$83.92

arrow_drop_up0.37%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

MetLife (MET) Stocklytics Forecast

MetLife Inc (MET) is a leading insurance company that operates globally. With its strong financial position and extensive customer base, the company is well-positioned for future growth. Analysts have provided positive forecasts for the stock price of MET, indicating potential opportunities for investors. According to AI and machine learning predictions, the stock price of MET is expected to steadily increase over the coming years. In particular, the stock price forecast for 2023 shows promising prospects for investors. The company's solid performance and strategic initiatives make it an attractive investment option.
Considering the price target for MET, analysts have projected a positive outlook. The price target for 2023 reveals an optimistic view for the stock, indicating potential gains for shareholders. The analyst ratings for MET also reflect positive sentiment, with experts recommending the stock as a good buy. Investors can have confidence in the future prospects of MET, given its strong fundamentals and growth strategies. The overall market outlook for the company is favorable, and it is expected to deliver value to its shareholders in the long run.
add MetLife  to watchlist

Keep an eye on MetLife

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for MetLife (MET) stock?

Analysts have set a target price of $79.83 for MetLife (MET), based on forecasts from 30 analysts. The predicted price range extends from a high of $87 to a low of $65. This represents a potential increase of up to 3.67% and a decrease of -22.55% from the current price of $83.92. These forecasts are as of 2023 May 26.
help

What are the analyst ratings for MetLife (MET) stock?

The analyst ratings for MetLife (MET) are distributed as follows: 12 analysts recommend buying, 3 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 16 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering MetLife .
help

What is the AI price prediction for MetLife (MET) stock?

At present, there is no AI or machine-learning-based price prediction available for MetLife (MET) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level